We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours.AuthorsStrumberg, D; Schultheis, B; Adamietz, I A; Christensen, O; Buechert, M; Kraetzschmar, J; Rajagopalan, P; Ludwig, M; Frost, A; Steinbild, S; Scheulen, M E; Mross, KPublicationBritish Journal of Cancer, 2008, Vol 99, Issue 10, p1579ISSN0007-0920Publication typearticleDOI10.1038/sj.bjc.6604724